All posts by: GIDM

About GIDM

PANITUMUMAB IN COMBINATION WITH INFUSIONAL OXALIPLATIN AND ORAL CAPECITABINE FOR CONVERSION THERAPY IN PATIENTS WITH COLON CANCER AND ADVANCED LIVER METASTASES

PANITUMUMAB IN COMBINATION WITH INFUSIONAL OXALIPLATIN AND ORAL CAPECITABINE FOR CONVERSION THERAPY IN PATIENTS WITH COLON CANCER AND ADVANCED LIVER METASTASES. The MetaPan Study. Francesco Leone; Salvatore Artale; Donatella Marino; Celeste Cagnazzo; Stefano Cascinu; Carmine Pinto; Giuseppe Fornarini; Marco Tampellini; Francesca Di Fabio; Andrea Sartore-Bianchi; Luciano De Carlis; Raffaele Pugliese; Lorenzo Capussotti; Luisa Gioeni; Salvatore Siena; and … Continue reading

Pubblicazioni

A CASE SERIES OF LOW DOSE BEVACIZUMAB AND CHEMOTHERAPY IN HEAVILY PRETREATED PATIENTS WITH EPITHELIAL OVARIAN CANCER.

 J Ovarian Res. 2012 Jun 25;5(1):17. doi: 10.1186/1757-2215-5-17. A CASE SERIES OF LOW DOSE BEVACIZUMAB AND CHEMOTHERAPY IN HEAVILY PRETREATED PATIENTS WITH EPITHELIAL OVARIAN CANCER. Defferrari C1, Campora S, D’Amico M, Piccardo A, Biscaldi E, Rosselli D, Pasa A, Puntoni M, Gozza A, Gennari A, Zanardi S, Lionetto R, Bandelloni M, Decensi … Continue reading

Pubblicazioni

AN OBSERVATIONAL STUDY OF NASAL CAVITY TOXICITY IN CANCER PATIENTS TREATED WITH BEVACIZUMAB

Expert Opin Drug Saf. 2014 Nov;13(11):1437-42. doi: 10.1517/14740338.2014.960388. Epub 2014 Sep 16. AN OBSERVATIONAL STUDY OF NASAL CAVITY TOXICITY IN CANCER PATIENTS TREATED WITH BEVACIZUMAB. D’Amico M1, Pagano M, Pasa A, Puntoni M, Clavarezza M, Gennari A, Gozza A, Zanardi S, Defferrari C, Provinciali N, Campazzi E, Campora S, Paleari L, Marra D, Petrera M, DeCensi A. &nbs… Continue reading

Pubblicazioni